Zobrazeno 1 - 10
of 194
pro vyhledávání: '"Raquel De Paz"'
P680: PONATINIB 15 MG AS CONSOLIDATION PRIOR TO TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA
Autor:
Valentin Garcia Gutierrez, Juan Carlos Hernandez-Boluda, Luis Felipe Casado Montero, M Teresa Gómez Casares, Rosa Ayala Diaz, Blanca Xicoy Cirici, Francisca Ferrer-Marín, Guillermo Ortí, Raquel De Paz Arias, Santiago Ossorio Prendes, Raúl Pérez López, Elvira Mora Castera, Concepcion Ruiz Nuño, Antonio Jimenez, Concepcion Boque Genovard, Magdalena Sierra, Joaquín Martinez-Lopez
Publikováno v:
HemaSphere, Vol 7, p e77404fb (2023)
Externí odkaz:
https://doaj.org/article/36457bc182dc4616965e2e0870a3656d
Autor:
Karima Al-Akioui Sanz, Carlos Echecopar Parente, Cristina Ferreras, Marta Menéndez Ribes, Alfonso Navarro, Carmen Mestre, Laura Clares, José Luis Vicario, Antonio Balas, Raquel De Paz, Eduardo López Granados, Elena Sánchez Zapardiel, Carlos Jiménez, María López-Oliva, Esther Ramos, Francisco Hernández-Oliveros, Antonio Pérez-Martínez
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundImmunocompromised patients are susceptible to high-risk opportunistic infections and malignant diseases. Most antiviral and antifungal drugs are quite toxic, relatively ineffective, and induce resistance in the long term. The transfer of pa
Externí odkaz:
https://doaj.org/article/1686827fd5484660b2e2b5b3552ae8d2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valentín Garcia-Gutiérrez, Alejandro Luna, Juan M. Alonso-Dominguez, Natalia Estrada, Concepcion Boque, Blanca Xicoy, Pilar Giraldo, Anna Angona, Alberto Alvarez-Larrán, Fermin Sanchez-Guijo, María José Ramírez, Elvira Mora, Patricia Vélez, Ana Rosell, Mercedes Colorado Araujo, Beatriz Cuevas, Miguel Sagüés, Montserrat Cortes, Manuel Perez Encinas, Luis Felipe Casado Montero, Melania Moreno Vega, Luis Serrano, Valle Gomez, Carmen Garcia-Hernandez, Sunil Lakhwani, Antonio Paz Coll, Raquel de Paz, Sara Suarez-Varela, Andrés Fernandez-Ruiz, Raul Perez Lopez, Almudena Ortiz-Fernández, Antonio Jiménez-Velasco, Juan Luis Steegmann-Olmedillas, Juan Carlos Hernández-Boluda
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/717b8583ea22422db39b5f3e0735ac0c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carmen De Ramón Ortiz, Raul Justo Sanz, Yan Beauverd, Karem Humala, Ana López de la Guia, Raquel De Paz, Mercedes Gasior, Pilar Gómez Prieto, Marta Fabra Urdiola, Miguel Canales Albendea, Nora Butta, Victor Jiménez Yuste
Publikováno v:
Disease Markers. 2023:1-9
Background. Sinusoidal obstructive syndrome (SOS) is a potentially fatal complication secondary to hematopoietic stem cell transplant (HSCT) conditioning. Endothelial damage plasma biomarkers such as plasminogen activator inhibitor-1 (PAI-1), hyaluro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a014e01c3b459b059fff6f8b62ac8113
https://doi.org/10.1155/2023/7589017
https://doi.org/10.1155/2023/7589017
Autor:
Karima Al-Akioui-Sanz, Bárbara Pascual-Miguel, Mariana Díaz-Almirón, Carmen Mestre-Durán, Alfonso Navarro-Zapata, Laura Clares-Villa, Carla Martín-Cortázar, José Luis Vicario, Miguel Ángel Moreno, Antonio Balas, Raquel De Paz, Jordi Minguillón, Antonio Pérez-Martínez, Cristina Ferreras
Publikováno v:
Cytotherapy. 25:330-340
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d993524e56a7bfb194a3295db534215e
https://doi.org/10.1016/j.jcyt.2022.12.001
https://doi.org/10.1016/j.jcyt.2022.12.001
Autor:
Lucía Pérez-Lamas, Alejandro Luna, Concepcion Boque, María Alicia Senin, Blanca Xicoy, Pilar Giraldo, Raul Perez Lopez, Concepción Ruiz Nuño, Natalia De las Heras, Elvira Mora Casterá, Carmen Garcia-Hernandez, Adrian Segura Diaz, Juan Luis Steegmann, Patricia Velez Tenza, Fermin Sanchez-Guijo, Ana Maria Garcia-Noblejas Moya, Juan Antonio Juan Vera Goñi, Melania Moreno Vega, Alberto Alvarez-Larran, Montse Cortes, Manuel Perez Encinas, Luis Serrano, Anna Angona, Ana Rosell, Sunil Lakhwani, Mercedes Colorado, Elena Ramila, Carlos Cervero, Beatriz Cuevas, Lucia Villalon Blanco, Juan Carlos Hernandez Boluda, Antonio Paz Coll, Valle Gómez García de Soria, Maria Jose Fernández, Luis Felipe Casado, Juan Manuel Alonso-Dominguez, Maria Magdalena Anguita Arance, Patricia Carrascosa Mastell, Araceli Salamanca Cuenca, Antonio Jiménez-Velasco, María José Ramírez, Miguel López Esteban, Magdalena Sierra Pacho, Marta Santaliestra, Olga Alda Alvarez, Raquel de Paz, Valentín García Gutiérrez
Publikováno v:
Blood. 140:3925-3928
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a512b511ab97a785526d10fc8736373e
https://doi.org/10.1182/blood-2022-167453
https://doi.org/10.1182/blood-2022-167453
Autor:
Lionel Adès, Larisa Girshova, Vadim A. Doronin, María Díez-Campelo, David Valcárcel, Suman Kambhampati, Nora-Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Achilles Anagnostopoulos, Eduardo Ciliao Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Sharon Friedlander, Douglas V. Faller, Mikkael A. Sekeres
Publikováno v:
Scientia
Pevonedistat; Chronic myelomonocytic leukemia Pevonedistat; Leucemia mielomonocítica crónica Pevonedistat; Leucèmia mielomonocítica crònica PANTHER is a global, randomized phase 3 trial of pevonedistat+azacitidine (n = 227) vs azacitidine monoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8838e72608b49d5e2a82c322c09cf86
https://doi.org/10.1182/bloodadvances.2022007334
https://doi.org/10.1182/bloodadvances.2022007334
Autor:
José A. García-Marco, Javier López Jiménez, Valle Recasens, Miguel Fernández Zarzoso, Eva González-Barca, Nieves Somolinos De Marcos, M. Jose Ramírez, Francisco Javier Peñalver Parraga, Lucrecia Yañez, Javier De La Serna Torroba, Maria Dolores Garcia Malo, Guillermo Deben Ariznavarreta, Ernesto Perez Persona, M. Angeles Ruiz Guinaldo, Raquel De Paz Arias, Elena Bañas Llanos, Isidro Jarque, M. del Carmen Fernandez Valle, Ana Carral Tatay, Jaime Perez De Oteyza, Eva Maria Donato Martin, Inmaculada Perez Fernández, Rafael Martinez Martinez, M. Angeles Andreu Costa, Diana Champ, Julio García Suarez, Marcos González Díaz, Secundino Ferrer, Félix Carbonell, José A. García-Vela
Publikováno v:
Haematologica, Vol 104, Iss 11 (2019)
It has been postulated that monitoring measurable residual disease (MRD) could be used as a surrogate marker of progression-free survival (PFS) in chronic lymphocytic leukemia (CLL) patients after treatment with immunochemotherapy regimens. In this s
Externí odkaz:
https://doaj.org/article/fb9a08ed52534cc49c34466240ad698c